In 1993, Fu et al. found that there was certain kind of autoantibody against M2AChR-el2 (M2-AA) in DCM patients, which suggested that autoimmune factors may participate in the development of DCM [2]. This evidence concerns the gene SPTA1 and familial dilated cardiomyopathy.